BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6542722)

  • 1. Immune responses of cattle following vaccination with living and non-living Babesia bovis antigens.
    Timms P; Stewart NP; Rodwell BJ; Barry DN
    Vet Parasitol; 1984 Nov; 16(3-4):243-51. PubMed ID: 6542722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge.
    Timms P; Dalgliesh RJ; Barry DN; Dimmock CK; Rodwell BJ
    Aust Vet J; 1983 Mar; 60(3):75-7. PubMed ID: 6347164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
    Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
    Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens.
    Montenegro-James S; Toro Benitez M; Leon E; Lopez R; Ristic M
    Parasitol Res; 1987; 74(2):142-50. PubMed ID: 3325981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine babesiosis: protection of cattle with culture-derived soluble Babesia bovis antigen.
    Smith RD; James MA; Ristic M; Aikawa M; Vega y Murguia CA
    Science; 1981 Apr; 212(4492):335-8. PubMed ID: 7209532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live and soluble antigens for cattle protection to Babesia bigemina.
    Echaide IE; de Echaide ST; Guglielmone AA
    Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
    Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
    Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period.
    Kuttler KL; Levy MG; Ristic M
    Am J Vet Res; 1983 Aug; 44(8):1456-9. PubMed ID: 6354014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium.
    Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ
    Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
    Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
    Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine babesiosis: failure to induce interferon gamma production in response to Babesia bovis antigens in cattle.
    Orinda GO; Gale KR; Wright IG; Parrodi F
    Int J Parasitol; 1992 May; 22(3):395-8. PubMed ID: 1639576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
    Brown WC; Palmer GH
    Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity in cattle to Babesia bovis after single infections with parasites of various origin.
    Mahoney DF; Wright IG; Goodger BV
    Aust Vet J; 1979 Jan; 55(1):10-2. PubMed ID: 435202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
    Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
    Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
    Figueroa JV; Precigout E; Carcy B; Gorenflot A
    Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.